ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,570Medicare Part D Prescriptions Filled, Including Refills

Rank: 198 out of 6969

$463K Total Retail Price of All Prescriptions

Rank: 714 out of 6969

743 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
26% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

11% of this provider’s 743 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

1% of this provider’s 12,930 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

16% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$34 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
SIMVASTATIN 865 786 1 1
OMEPRAZOLE 787 734 2 6
BENAZEPRIL HCL 670 666 3 18
LEVOTHYROXINE SODIUM 633 609 4 5
AMLODIPINE BESYLATE 542 530 5 4
METFORMIN HCL 525 511 6 7
HYDROCHLOROTHIAZIDE 522 492 7 8
ATENOLOL 440 425 8 9
ALENDRONATE SODIUM 371 362 9 14
LISINOPRIL 344 337 10 2
LOVASTATIN 337 327 11 15
METOPROLOL TARTRATE 305 294 12 13
FUROSEMIDE 266 261 13 10
GLIPIZIDE 233 232 14 21
LOSARTAN POTASSIUM 231 212 15 12
TAMSULOSIN HCL 219 203 16 23
HYDROCODONE-ACETAMINOPHEN 213 198 S3 17 3
CITALOPRAM HBR 212 210 18 34
LORAZEPAM 161 157 19 186
AZITHROMYCIN 150 145 20 42
FLUTICASONE PROPIONATE 145 134 21 24
IBUPROFEN 116 110 22 29
INSULIN SYRINGE 101 100 23 60
POTASSIUM CHLORIDE 101 99 23 30
DIOVAN 100 95 25 26
ZOLPIDEM TARTRATE 98 98 26 16
CLOPIDOGREL 98 96 26 48
SPIRIVA 97 90 28 66
ISOSORBIDE MONONITRATE ER 92 80 29 81
CIPROFLOXACIN HCL 92 78 29 64
PLAVIX 90 88 31 68
CARVEDILOL 87 87 32 25
DOXAZOSIN MESYLATE 87 87 32 74
LANTUS 86 86 34 50
BENAZEPRIL-HYDROCHLOROTHIAZIDE 85 71 35 132
PANTOPRAZOLE SODIUM 83 77 36 31
LIPITOR 80 72 37 89
FAMOTIDINE 80 64 37 37
ADVAIR DISKUS 72 64 39 45
ALPRAZOLAM 71 57 40 172
GLIMEPIRIDE 70 69 41 44
FINASTERIDE 69 69 42 80
TRIAMTERENE-HCTZ 69 65 42 58
MECLIZINE HCL 66 65 44 100
OXYBUTYNIN CHLORIDE 65 65 45 126
PRAVASTATIN SODIUM 64 64 46 19
PROAIR HFA 64 62 46 33
NIFEDIPINE ER 63 63 48 95
PAROXETINE HCL 63 63 48 65
GLYBURIDE 60 60 R 50 54
VERAPAMIL ER 59 59 51 133
LACTULOSE 59 57 51 131
GABAPENTIN 59 57 51 17
GEMFIBROZIL 56 56 54 85
ATORVASTATIN CALCIUM 54 54 55 11
ALBUTEROL SULFATE 54 54 55 123
LOSARTAN-HYDROCHLOROTHIAZIDE 54 54 55 53
DIGOXIN 53 49 58 71
ACETAMINOPHEN-CODEINE 52 52 S3 59 73
ENALAPRIL MALEATE 50 47 60 56
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 11, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.